Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Buono

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reviews|June 26, 2018
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeL Gerratana, D Basile, G Buono, et al.
Nature Communications|September 9, 2024
Site-specific template generative approach for retrosynthetic planningYu Shee, Haote Li, Pengpeng Zhang, et al.
The Journal of Organic Chemistry|August 22, 2014
Synthesis of the 6-azaindole containing HIV-1 attachment inhibitor pro-drug, BMS-663068Ke Chen, Christina Risatti, Michael Bultman, et al.
Nature|January 19, 2026
Collective intelligence for AI-assisted chemical synthesisHaote Li, Sumon Sarkar, Wenxin Lu, et al.
Microbiology Resource Announcements|October 13, 2022
Draft Genome Sequences for 6 Isolates of Endospore-Forming Class <i>Bacilli</i> Species Isolated from Soil from a Suburban, Wooded, Developed SpaceAnna L McLoon, Thomas T Awad, Molly F Bogardus, et al.
Current Research in Translational Medicine|May 4, 2016
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean womenA Crispo, M Montella, G Buono, et al.
Organic Letters|August 26, 2014
Addressing the configuration stability of lithiated secondary benzylic carbamates for the development of a noncryogenic stereospecific boronate rearrangementKeith R Fandrick, Nitinchandra D Patel, Jason A Mulder, et al.
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
Journal of the American Chemical Society|November 1, 2016
Sequential C-H Arylation and Enantioselective Hydrogenation Enables Ideal Asymmetric Entry to the Indenopiperidine Core of an 11β-HSD-1 InhibitorXudong Wei, Bo Qu, Xingzhong Zeng, et al.
The Journal of Organic Chemistry|January 7, 2015
Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitorKeith R Fandrick, Jason A Mulder, Nitinchandra D Patel, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reviews|June 26, 2018
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeL Gerratana, D Basile, G Buono, et al.
Nature Communications|September 9, 2024
Site-specific template generative approach for retrosynthetic planningYu Shee, Haote Li, Pengpeng Zhang, et al.
The Journal of Organic Chemistry|August 22, 2014
Synthesis of the 6-azaindole containing HIV-1 attachment inhibitor pro-drug, BMS-663068Ke Chen, Christina Risatti, Michael Bultman, et al.
Nature|January 19, 2026
Collective intelligence for AI-assisted chemical synthesisHaote Li, Sumon Sarkar, Wenxin Lu, et al.
Microbiology Resource Announcements|October 13, 2022
Draft Genome Sequences for 6 Isolates of Endospore-Forming Class <i>Bacilli</i> Species Isolated from Soil from a Suburban, Wooded, Developed SpaceAnna L McLoon, Thomas T Awad, Molly F Bogardus, et al.
Current Research in Translational Medicine|May 4, 2016
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean womenA Crispo, M Montella, G Buono, et al.
Organic Letters|August 26, 2014
Addressing the configuration stability of lithiated secondary benzylic carbamates for the development of a noncryogenic stereospecific boronate rearrangementKeith R Fandrick, Nitinchandra D Patel, Jason A Mulder, et al.
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
Journal of the American Chemical Society|November 1, 2016
Sequential C-H Arylation and Enantioselective Hydrogenation Enables Ideal Asymmetric Entry to the Indenopiperidine Core of an 11β-HSD-1 InhibitorXudong Wei, Bo Qu, Xingzhong Zeng, et al.
The Journal of Organic Chemistry|January 7, 2015
Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitorKeith R Fandrick, Jason A Mulder, Nitinchandra D Patel, et al.
Pageof 6